ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.60
+0.51 (2.31%)
At close: Jun 23, 2026, 4:00 PM EDT
22.15
-0.45 (-1.99%)
After-hours: Jun 23, 2026, 4:18 PM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,372,494
Profits / Employee
$470,739
Market Cap
3.87B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| Parabilis Medicines | 145 |
| Tango Therapeutics | 137 |
ACAD News
- 5 weeks ago - ACADIA Pharmaceuticals Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - ACADIA Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi - TheFly
- 6 weeks ago - Acadia Pharmaceuticals reports Q1 EPS 2c, consensus 8c - TheFly
- 6 weeks ago - Acadia Pharmaceuticals backs FY26 revenue view $1.22B-$1.28B, consensus $1.25B - TheFly
- 6 weeks ago - ACADIA Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - ACADIA Pharmaceuticals Slides: Q1 2026 - Filings
- 6 weeks ago - ACADIA Pharmaceuticals Earnings release: Q1 2026 - Filings